Literature DB >> 16286616

Bimatoprost-induced periocular skin hyperpigmentation: histopathological study.

Rashmi Kapur1, Smajo Osmanovic, Sami Toyran, Deepak P Edward.   

Abstract

OBJECTIVE: To investigate light microscopic and ultrastructural changes in bimatoprost-induced skin hyperpigmentation.
METHODS: Eyelid biopsy specimens from bimatoprost-treated patients and matched controls were examined by light microscopy and transmission electron microscopy. Using an image analyzer, melanin granules were counted on Fontana-Masson-stained sections, and melanosomes were counted on electron micrographs. Immunohistochemical analysis was performed with antibodies against S100 and CD3. Positively labeled cells were counted.
RESULTS: By light microscopy, a marked increase in the number of melanin granules was noted in the bimatoprost-treated specimens. Electron microscopy demonstrated dermal melanocytes with prominent rough endoplasmic reticulum and abundant normal-sized melanosomes in different stages of maturation as compared with control specimens. Furthermore, the keratinocytes of the bimatoprost-treated specimens showed abundant mature melanosomes when compared with controls. Also of note, atypical melanocytes were absent in both specimens. The S100-positive melanocytes were comparable in bimatoprost-treated and control specimens. Few CD3- and CD68-positive cells in the bimatoprost-treated specimens were noted in both groups.
CONCLUSION: Bimatoprost-induced periocular hyperpigmentation is caused by increased melanogenesis. There was no evidence of melanocyte proliferation or prostaglandin-induced inflammation in the specimens that were examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286616     DOI: 10.1001/archopht.123.11.1541

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

Review 1.  [Suprachoroidal minimally invasive glaucoma surgery : Procedures and clinical outcome].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

2.  Iris heterochromia and unilateral eyelash hypertrichosis.

Authors:  Rajesh C Rao; Tiffany N S Ballard; Teresa C Chen
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

3.  Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical Trials.

Authors:  David Wirta; David M Pariser; Steven G Yoelin; Seiji Arase; Amy McMichael; Emily Weng; Cheri Mao; George Demos; Amanda Vandenburgh
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

4.  Travoprost in the management of open-angle glaucoma and ocular hypertension.

Authors:  Philippe Denis; David Covert; Anthony Realini
Journal:  Clin Ophthalmol       Date:  2007-03

5.  Bimatoprost in the treatment of eyelash hypotrichosis.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2010-04-26

6.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 7.  Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost.

Authors:  Firas Constantin Kreeshan; Vishal Madan
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

9.  Management of hypotrichosis of the eyelashes: Focus on bimatoprost.

Authors:  Steven Fagien
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-13

Review 10.  Enhanced eyelashes: prescription and over-the-counter options.

Authors:  Derek Jones
Journal:  Aesthetic Plast Surg       Date:  2010-08-21       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.